Quadrant Capital Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Quadrant Capital Group’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-63	Closed	-$10K	–	2745
2021 Q2	$10K	Hold	63	–	–	﹤0.01%	1600
2021 Q1	$10K	Buy	63 +24	+62%	+$3.26K	﹤0.01%	1521
2020 Q4	$5K	Sell	39 -32	-45%	-$3.58K	﹤0.01%	1726
2020 Q3	$7K	Buy	71 +5	+8%	+$510	﹤0.01%	1427
2020 Q2	$6K	Buy	66 +21	+47%	+$1.95K	﹤0.01%	1608
2020 Q1	$4K	Sell	45 -345	-88%	-$33.6K	﹤0.01%	1738
2019 Q4	$43K	Hold	390	–	–	0.01%	1415
2019 Q3	$38K	Buy	+390	New	+$38.7K	0.01%	1338
2019 Q2	–	Sell	-42	Closed	-$4K	–	2443
2019 Q1	$4K	Buy	42 +22	+110%	+$2.3K	﹤0.01%	1948
2018 Q4	$1K	Buy	+20	New	+$2.02K	﹤0.01%	2142

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Quadrant Capital Group's PRAH Position: Q3 2021 in Review

Quadrant Capital Group sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 63 shares — an estimated $10K sold.

Quadrant Capital Group first reported a position in PRAH in Q4 2018 and held it in 10 quarters. The position peaked at $43K in Q4 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Quadrant Capital Group reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Quadrant Capital Group sold 63 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $10K.
Quadrant Capital Group first reported a position in PRA Health Sciences, Inc. in Q4 2018 and held it in 10 quarters.
Quadrant Capital Group's PRA Health Sciences, Inc. position peaked at $43K in Q4 2019.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Quadrant Capital Group's 13F filing for Q3 2021, filed 12 Nov 2021.